Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonin and epilepsy: the story continues.

Literature DB >> 24348131

Serotonin and epilepsy: the story continues.

Barry E Gidal.

Abstract

Entities: Chemical Disease

Year: 2013 PMID： 24348131 PMCID： PMC3854748 DOI： 10.5698/1535-7597-13.6.289

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

Keyword Cloud
References

× No keyword cloud information.

15 in total

1. The insular cortex and the neuroanatomy of major depression.

Authors: Reiner Sprengelmeyer; J Douglas Steele; Benson Mwangi; Poornima Kumar; David Christmas; Maarten Milders; Keith Matthews
Journal: J Affect Disord Date: 2011-04-29 Impact factor: 4.839

Review 2. Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design.

Authors: Kajsa M Igelström
Journal: Epilepsia Date: 2012-03-14 Impact factor: 5.864

Review 3. Pathophysiology of mood disorders in temporal lobe epilepsy.

Authors: Ludmyla Kandratavicius; Rafael Naime Ruggiero; Jaime Eduardo Hallak; Norberto Garcia-Cairasco; João Pereira Leite
Journal: Braz J Psychiatry Date: 2012-10 Impact factor: 2.697

4. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.

Authors: I Savic; P Lindström; B Gulyás; C Halldin; B Andrée; L Farde
Journal: Neurology Date: 2004-04-27 Impact factor: 9.910

5. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy.

Authors: Joyce A Cramer; David Blum; Kristina Fanning; Michael Reed
Journal: Epilepsy Behav Date: 2004-06 Impact factor: 2.937

Review 6. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

Authors: Hamada Hamid; Andres M Kanner
Journal: Epilepsy Behav Date: 2013-02-08 Impact factor: 2.937

Serotonin and epilepsy: the story continues.

1. The insular cortex and the neuroanatomy of major depression.

Review 2. Preclinical antiepileptic actions of selective serotonin reuptake inhibitors--implications for clinical trial design.

Review 3. Pathophysiology of mood disorders in temporal lobe epilepsy.

4. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.

5. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy.

Review 6. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

7. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy.

8. The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography.

Review 9. Depression in epilepsy: a systematic review and meta-analysis.

10. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy.